InfuSystem Holdings Inc
Research InfuSystem Holdings Inc (INFU) on Bullrun: valuation model: 26.9% overvalued, market cap USD 270.83M, P/E 33.4. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerINFU
- ExchangeNYSE MKT
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Valuation signal26.9% overvalued
- Market capUSD 270.83M
- P/E33.4
- Financial periodQ2 2026
- RevenueUSD 36.93M
- Net incomeUSD 3.23M
- Free cash flowUSD 1.82M
- Gross margin58.0%
Valuation Snapshot
Bullrun's latest valuation model marks InfuSystem Holdings Inc as 26.9% overvalued; latest market cap is USD 270.83M; P/E is 33.4.
Peer valuation comparison
Latest P/E is 33.37x versus a Healthcare sector median of 24.6x (35.7% above).
Latest P/E is 33.37x versus a United States median of 23.85x (39.9% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 143.44M | USD 6.63M | USD 23.85M | 56.0% | 0.31 | USD 3.19M | USD 19.63M | USD 57.33M |
| FY2024 | USD 134.86M | USD 2.35M | USD 19.37M | 52.2% | 0.11 | USD 527.00K | USD 23.86M | USD 57.53M |
| FY2023 | USD 125.79M | USD 872.00K | USD 10.20M | 50.2% | 0.04 | USD 231.00K | USD 29.10M | USD 52.30M |
| FY2022 | USD 109.91M | USD 18.00K | USD 16.54M | 55.1% | 0 | USD 165.00K | USD 33.16M | USD 48.00M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 270.83M | 33.4 | n/a | n/a |
| 2025 | 2025-12-31 | USD 181.28M | 28.0 | n/a | n/a |
| 2024 | 2024-12-31 | USD 179.75M | 76.8 | n/a | n/a |
| 2023 | 2023-12-29 | USD 223.27M | 263.5 | n/a | n/a |
| 2022 | 2022-12-30 | USD 179.30M | 868.0 | n/a | n/a |
| 2021 | 2021-12-31 | USD 352.51M | 283.8 | n/a | n/a |
About InfuSystem Holdings Inc
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.
Related stock research
Other Healthcare stocks
Frequently asked questions
Is InfuSystem Holdings Inc overvalued or undervalued?
Bullrun's valuation model currently marks InfuSystem Holdings Inc as 26.9% overvalued.
What is InfuSystem Holdings Inc's market cap?
InfuSystem Holdings Inc's market capitalization is USD 270.83M.
What is InfuSystem Holdings Inc's P/E ratio?
InfuSystem Holdings Inc's price-to-earnings (P/E) ratio is 33.4.
What does InfuSystem Holdings Inc do?
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.